BackAIM ImmunoTech Overview

AIM ImmunoTech Receivables

Track AIM ImmunoTech's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average / median

Loading

AIM ImmunoTech Receivables History

Loading

AIM ImmunoTech vs. peers: Receivables Comparison

Loading

AIM ImmunoTech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AIM ImmunoTech (AIM) FAQ

AIM ImmunoTech posts a receivables of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, AIM ImmunoTech's receivables was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of AIM ImmunoTech's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AIM's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; AIM ImmunoTech's other metric pages and overview cover the third.

Judging AIM ImmunoTech against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.